Literature DB >> 4060580

Alterations in the hemagglutinin associated with adaptation of influenza B virus to growth in eggs.

J S Robertson, C W Naeve, R G Webster, J S Bootman, R Newman, G C Schild.   

Abstract

In 1943 Burnet reported on changes in the hemagglutinating properties of human influenza virus which occurred during adaptation of the virus to growth in chicken eggs. Only recently has direct evidence been presented that these changes affect the antigenic properties of the virus. Schild et al. (G. C. Schild, J. S. Oxford, J. C. deJong, and R. G. Webster (1983), Nature (London) 303, 706-709) demonstrated that egg adaptation of influenza B virus selects variants which are antigenically distinct from virus grown from the same source in mammalian cells. The molecular changes in the hemagglutinin (HA) of influenza B virus associated with adaptation to growth in eggs have now been identified. A specific glycosylation site at the distal tip of the HA of influenza B virus grown exclusively in mammalian cell culture is lost or altered during egg adaptation. Since the HA functions in adsorption of virus to cells, it is concluded that removal or modification of an oligosaccharide structure at this position is required for influenza B virus to attach to and infect the allantois cells of the egg and that this has important implications for the antigenic configuration of the molecule.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4060580     DOI: 10.1016/0042-6822(85)90105-9

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  71 in total

1.  Post-translational modifications in insect cells.

Authors:  H D Klenk
Journal:  Cytotechnology       Date:  1996-01       Impact factor: 2.058

Review 2.  Avian influenza pandemic preparedness: developing prepandemic and pandemic vaccines against a moving target.

Authors:  Neetu Singh; Aseem Pandey; Suresh K Mittal
Journal:  Expert Rev Mol Med       Date:  2010-04-29       Impact factor: 5.600

3.  Pathogenesis of bronchiolitis and pneumonia induced in neonatal and weanling rats by parainfluenza (Sendai) virus.

Authors:  W L Castleman; L J Brundage-Anguish; L Kreitzer; S B Neuenschwander
Journal:  Am J Pathol       Date:  1987-11       Impact factor: 4.307

4.  Single amino acid substitutions in the hemagglutinin can alter the host range and receptor binding properties of H1 strains of influenza A virus.

Authors:  S Aytay; I T Schulze
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

5.  Regulation of receptor binding affinity of influenza virus hemagglutinin by its carbohydrate moiety.

Authors:  M Ohuchi; R Ohuchi; A Feldmann; H D Klenk
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

6.  Bringing influenza vaccines into the 21st century.

Authors:  Ethan C Settembre; Philip R Dormitzer; Rino Rappuoli
Journal:  Hum Vaccin Immunother       Date:  2013-12-30       Impact factor: 3.452

7.  Antigenic heterogeneity within influenza A (H3N2) virus strains.

Authors:  J C de Jong; F M de Ronde-Verloop; T M Veenendaal-van Herk; T F Weijers; K Bijlsma; A D Osterhaus
Journal:  Bull World Health Organ       Date:  1988       Impact factor: 9.408

8.  Analysis of N-glycans in embryonated chicken egg chorioallantoic and amniotic cells responsible for binding and adaptation of human and avian influenza viruses.

Authors:  Nongluk Sriwilaijaroen; Sachiko Kondo; Hirokazu Yagi; Prapon Wilairat; Hiroaki Hiramatsu; Morihiro Ito; Yasuhiko Ito; Koichi Kato; Yasuo Suzuki
Journal:  Glycoconj J       Date:  2008-10-14       Impact factor: 2.916

9.  Host cell-mediated selection of influenza A (H3N2) virus variant subpopulations: lack of association between antigenic and receptor-binding properties.

Authors:  R Pyhälä; L Pyhälä; P Pekkala
Journal:  Epidemiol Infect       Date:  1988-06       Impact factor: 2.451

10.  Sequence of an influenza virus hemagglutinin determined directly from a clinical sample.

Authors:  A Rajakumar; E M Swierkosz; I T Schulze
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.